Clearside Biomedical, Inc. (CLSD)
CLSD has a market cap or net worth of $63.03 million. The enterprise value is $76.03 million.
The last earnings date was Monday, November 13, 2023, after market close.
|Earnings Date||Nov 13, 2023|
CLSD has 62.41 million shares outstanding. The number of shares has increased by 2.98% in one year.
|Shares Change (YoY)||+2.98%|
|Shares Change (QoQ)||+0.53%|
|Owned by Insiders (%)||7.20%|
|Owned by Institutions (%)||27.28%|
|EV / Earnings||n/a|
|EV / Sales||34.39|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 5.28
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||-88.00%|
|Return on Capital (ROIC)||-103.63%|
|Revenue Per Employee||$61,417|
|Profits Per Employee||-$1.04M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -9.01% in the last 52 weeks. The beta is 2.18, so CLSD's price volatility has been higher than the market average.
|52-Week Price Change||-9.01%|
|50-Day Moving Average||0.88|
|200-Day Moving Average||1.05|
|Relative Strength Index (RSI)||57.74|
|Average Volume (30 Days)||117,276|
Short Selling Information
The latest short interest is 290,630, so 0.47% of the outstanding shares have been sold short.
|Short Previous Month||344,521|
|Short % of Shares Out||0.47%|
|Short % of Float||0.54%|
|Short Ratio (days to cover)||2.71|
In the last 12 months, CLSD had revenue of $2.21 million and -$37.32 million in losses. Loss per share was -$0.61.
|Loss Per Share||-$0.61|
The company has $28.80 million in cash and $41.80 million in debt, giving a net cash position of -$12.99 million or -$0.21 per share.
|Cash & Cash Equivalents||28.80M|
|Net Cash Per Share||-$0.21|
|Equity / Book Value||-12.85M|
|Book Value Per Share||-0.21|
In the last 12 months, operating cash flow was -$24.24 million and capital expenditures -$1.75 million, giving a free cash flow of -$25.99 million.
|Operating Cash Flow||-24.24M|
|Free Cash Flow||-25.99M|
|FCF Per Share||-$0.42|
Gross margin is 74.72%, with operating and profit margins of -1,356.81% and -1,687.74%.
Dividends & Yields
CLSD does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for CLSD is $5.25, which is 419.80% higher than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||419.80%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||126.05%|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|
CLSD has an Altman Z-Score of -14.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.